Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
Practical applications on new data of genetic ALL subtypes
Prof Robin Foà - Sapienza University of Rome, Rome, Italy
Practical applications on new data of genetic ALL subtypes ( Prof Robin Foà - Sapienza University of Rome, Rome, Italy )
10 Nov 2021
Triple class refractory multiple myeloma
Prof Joseph Mikhael - Translational Genomics Research Institute (TGen), Phoenix,...
Triple class refractory multiple myeloma ( Prof Joseph Mikhael - Translational Genomics Research Institute (TGen), Phoenix, USA )
10 Nov 2021
Managing high-risk/MRD positive and standard-risk/MRD myeloma
Dr Stefania Oliva - GIMEMA, European Myeloma Network, Italy
Managing high-risk/MRD positive and standard-risk/MRD myeloma ( Dr Stefania Oliva - GIMEMA, European Myeloma Network, Italy )
29 Oct 2021
Minimum residual disease techniques in myeloma
Dr Stefania Oliva - GIMEMA, European Myeloma Network, Italy
Minimum residual disease techniques in myeloma ( Dr Stefania Oliva - GIMEMA, European Myeloma Network, Italy )
29 Oct 2021
Identifying and treating high-risk/MRD positive newly diagnosed multiple myeloma
Prof Wee Joo Chng - National University Cancer Institute, Singapore
Identifying and treating high-risk/MRD positive newly diagnosed multiple myeloma ( Prof Wee Joo Chng  - National University Cancer Institute, Singapore )
29 Oct 2021
High-risk SMM imaging and NDMM treatment
Dr Elena Zamagni - University of Bologna, Bologna, Italy
High-risk SMM imaging and NDMM treatment ( Dr Elena Zamagni - University of Bologna, Bologna, Italy )
28 Oct 2021
Rescue after daratumumab failure
Prof Joseph Mikhael - Translational Genomics Research Institute (TGen), Phoenix,...
Rescue after daratumumab failure ( Prof Joseph Mikhael - Translational Genomics Research Institute (TGen), Phoenix, USA )
26 Oct 2021
MRD-driven strategies and novel immunotherapies for multiple myeloma
Prof Simon Harrison - Peter MacCallum Cancer Centre, Melbourne, Australia
MRD-driven strategies and novel immunotherapies for multiple myeloma ( Prof Simon Harrison - Peter MacCallum Cancer Centre, Melbourne, Australia )
25 Oct 2021
How to approach pain management in myeloma patients
Prof Wolfgang Grisold - Medical University of Vienna, Vienna, Austria
How to approach pain management in myeloma patients ( Prof Wolfgang Grisold - Medical University of Vienna, Vienna, Austria )
20 Oct 2021
Refractoriness and retreatment in the era of lenalidomide and mABs in the frontl...
Dr Fredrik Schjesvold - Oslo Myeloma Center, Oslo, Norway
Refractoriness and retreatment in the era of lenalidomide and mABs in the frontline myeloma setting ( Dr Fredrik Schjesvold - Oslo Myeloma Center, Oslo, Norway )
18 Oct 2021
Melflufen and dexamethasone vs pomalidomide and dexamethasone in relapsed refrac...
Dr Fredrik Schjesvold - Oslo Myeloma Center, Oslo, Norway
Melflufen and dexamethasone vs pomalidomide and dexamethasone in relapsed refractory multiple myeloma ( Dr Fredrik Schjesvold - Oslo Myeloma Center, Oslo, Norway )
21 Sep 2021
New MM patients with high levels of circulating tumour cells distinguished by in...
Dr Cathelijne Fokkema - Erasmus MC Cancer Institute, Rotterdam, Netherlands
New MM patients with high levels of circulating tumour cells distinguished by increased bone marrow plasma cell proliferation ( Dr Cathelijne Fokkema - Erasmus MC Cancer Institute, Rotterdam, Netherlands )
21 Sep 2021